Medicines360 Appoints Elizabeth Garner, M.D., M.P.H. to Board of Directors
Retrieved on:
Thursday, May 12, 2022
Jean Corston, Baroness Corston, Food, Gardasil, Multimedia, Patient, Woman, Policy, View, Health, Therapy, MPH, Color, FDA, SAN, American Medical Women's Association, DIA, Board, Food and Drug Administration, Board of directors, AMWA, Agile, HPV, CEO, Pharmaceutical industry, Medical device, Contraceptive patch, MD
SAN FRANCISCO, May 12, 2022 /PRNewswire/ -- Medicines360, the mission-driven nonprofit women's health pharmaceutical organization, has appointed Elizabeth Garner MD, MPH, as a member of its Board of Directors, effective immediately.
Key Points:
- SAN FRANCISCO, May 12, 2022 /PRNewswire/ -- Medicines360, the mission-driven nonprofit women's health pharmaceutical organization, has appointed Elizabeth Garner MD, MPH, as a member of its Board of Directors, effective immediately.
- "Every day, women face systemic challenges accessing high-quality, affordable medicines, which disproportionately impacts those with low incomes and communities of color," said Dr. Garner.
- "Born and raised in Nigeria, I was aware of global inequities in access to care from an early age.
- "Medicines360 is better poised than ever to develop accessible and high-quality medicines that are essential to women's healthcare," said Lisa David, CEO of Public Health Solutions, and a Medicines360 Board member.